Hexosaminidase A Antikörper (AA 89-529)
Kurzübersicht für Hexosaminidase A Antikörper (AA 89-529) (ABIN5775909)
Target
Alle Hexosaminidase A (HEXA) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 89-529
-
Verwendungszweck
- Human Hexosaminidase A/HEXA antibody
-
Aufreinigung
- Purified
-
Immunogen
- Recombinant human HEXA (89-529aa) purified from E. coli
-
Isotyp
- IgG2a lambda
-
-
-
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- Phosphate-Buffered Saline ( pH 7.4) with 0.02 % Sodium Azide, 10 % glycerol
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing cycles
-
Lagerung
- 4 °C,-20 °C,-80 °C
-
Informationen zur Lagerung
- Can be stored at +2C to +8C for 1 week. For long term storage, aliquot and store at -20C to -80C. Avoid repeated freezing and thawing cycles.
-
-
- Hexosaminidase A (HEXA)
-
Andere Bezeichnung
- Hexosaminidase A/HEXA
-
Hintergrund
- HEXA (Hexosaminidase A), also designated beta-Hexosaminidase A, is responsible for the degradation of GM2 gangliosides, and a variety of other molecules containing terminal N-acetyl hexosamines, in the brain and other tissues. A mutation in the a subunit of hexosaminidase is the cause of Tay-Sachs disease (TSD), also known as GM2-gangliosidosis type I. TSD is a fatal autosomal recessive lysosomal storage disease of the central nervous system (CNS) caused by insufficient activity of the HEXA enzyme that results in a failure to process GM2 gangliosides. The accumulation of GM2 ganglioside in the absence of HEXA activity causes progressive destruction of the CNS.
-
NCBI Accession
- NP_000511
-
Pathways
- Sensory Perception of Sound, Glycosaminoglycan Metabolic Process
Target
-